ENXTAM:AKZA
ENXTAM:AKZAChemicals

How Cevian Capital’s Stake and Board Support Will Impact Akzo Nobel (ENXTAM:AKZA) Investors

On August 22, 2025, Cevian Capital announced it had acquired a 3.02% stake in Akzo Nobel and publicly backed the company’s board and management to deliver on strategic priorities. This move by a prominent activist investor highlights an external push for enhanced operating performance and portfolio focus at Akzo Nobel. We'll explore how Cevian Capital's involvement and vote of confidence may impact Akzo Nobel's outlook and ongoing transformation narrative. The end of cancer? These 29...
ENXTAM:AGN
ENXTAM:AGNInsurance

How Investors Are Reacting To Aegon (ENXTAM:AGN) Return to Profit, Dividend Hike, and Expanded Buyback

Aegon Ltd. recently reported results for the half year ended June 30, 2025, achieving a net income of €584 million after reporting a net loss during the same period a year earlier, while also announcing an interim dividend increase of €0.03 per common share to €0.19 and upsizing its share buyback authorization to €400 million. This combination of a strong earnings turnaround, higher shareholder returns through dividends, and expanded buyback authorization reflects improved business momentum...